1-6 of 6
Mohammed Al-Adhami
Close
Sort by
Journal Articles

A Real-World Evidence Review of Post-Marketing Safety and Compliance with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the US

Carlos M de Castro, David Dingli, Mohammed Al-Adhami, Brian Mulherin, Michael Yeh, Stacie Lallier, Jesse Fishman
Journal: Blood
Blood (2023) 142 (Supplement 1): 5647.
https://doi.org/10.1182/blood-2023-181917
Published: 2023
Journal Articles

Pegcetacoplan Corrects Hyperbilirubinemia in Both Untreated Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and in Patients with PNH Who Previously Received Eculizumab

David J. Araten, Michael Yeh, Mohammed Al-Adhami, Regina Horneff, Federico Grossi
Journal: Blood
Blood (2022) 140 (Supplement 1): 11447–11448.
https://doi.org/10.1182/blood-2022-166623
Published: 2022
Journal Articles

A Matching-Adjusted Indirect Comparison of the Efficacy of Pegcetacoplan Using Prince Trial Data Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria

Raymond Wong, Jesse Fishman, Koo Wilson, Mohammed Al-Adhami, Michael Yeh, Zalmai Hakimi, Christopher Yee, Lynn Huynh, Mei Sheng Duh
Journal: Blood
Blood (2022) 140 (Supplement 1): 11435–11437.
https://doi.org/10.1182/blood-2022-160197
Published: 2022
Journal Articles

Efficacy and Safety of Pegcetacoplan Treatment in Complement-Inhibitor Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Phase 3 Prince Study

Raymond S Wong, Juan Ramon Navarro, Narcisa Sonia Comia, Yeow Tee Goh, Henry Idrobo, Daolada Kongkabpan, David Gomez-Almaguer, Mohammed Al-Adhami, Temitayo Ajayi, Paulo Alvarenga, Pascal Deschatelets, Cedric Francois, Federico Grossi, Teresita Dumagay
Journal: Blood
Blood (2021) 138 (Supplement 1): 606.
https://doi.org/10.1182/blood-2021-147493
Published: 2021
Journal Articles

Categorized Hematologic Response to Pegcetacoplan and Correlations with Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria: Post Hoc Analysis of Data from Phase 1b, Phase 2a, and Phase 3 Trials

Antonio Risitano, Raymond S Wong, Mohammed Al-Adhami, Crystal Chen, Regis Peffault De Latour
Journal: Blood
Blood (2021) 138 (Supplement 1): 1104.
https://doi.org/10.1182/blood-2021-147988
Published: 2021
Journal Articles

Post Hoc Analysis of the Effect of Pegcetacoplan Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria and Baseline Hemoglobin Levels Greater Than 10 Grams per Deciliter

Jens Panse, Nicolas Daguindau, Sonia Okuyama Sasaki, Regis Peffault De Latour, Philippe Schafhausen, Nicole Straetmans, Mohammed Al-Adhami, Temitayo Ajayi, Crystal Chen, Michael Yeh, Raymond S Wong
Journal: Blood
Blood (2021) 138 (Supplement 1): 2194.
https://doi.org/10.1182/blood-2021-146962
Published: 2021